Geovax Labs

GeoVax is a Biotechnology company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus - AIDS) and other infectious agents. Our goals include: developing AIDS vaccines for global markets, manufacturing and testing these vaccines under GMP/GLP conditions (FDA guidelines), conducting phase I/II and III human trials for vaccine safety and effectiveness and obtaining regulatory approval of these vaccines in the USA and specified international markets. Outstanding preclinical results: GeoVax DNA/MVA vaccine protected 96% of non-human primates for over 3½ yrs. To our knowledge, this level of protection has not been achieved by other candidate vaccines. Successful Phase I Human clinical DNA vaccine trials have demonstrated the safety of our vaccine(details). After receiving ”Safe to Proceed” status for a new Investigational New Drug (IND) by the U.S. Food and Drug Administration (FDA), Phase IA/IB trial (1/10th dose) combining DNA with MVA began in May 2006. Another trial (full dose) began in September 2006. These trials test various combinations and doses of our DNA and MVA AIDS vaccines in human volunteers for their ability to raise Anti-AIDS immune responses as well as for their safety. Long term, we expect that GeoVax will enter into agreements to out-license manufacturing technology to major vaccine production companies and distribution rights to key companies in several global markets in return for upfront fees, collaborative development agreements, and royalties on sales and distribution revenues. Internal vaccine manufacture and sale will be considered by GeoVax.

Contact Details: 1256 Briarcliff Road Atlanta GA 30306 United States of America Tel: 404/727-0971 Fax: 404/712-9357 Email: WWW: www.geovax.com/

Loading...

BioNews Results for Geovax Labs:
GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update	Pharmacy Choice:  Nov 12 2009 9:29PM Matching: geovax labs
GeoVax Labs announces financial results and operational update for the third quarter of 2009	News-Medical.Net:  Nov 7 2009 5:33AM Matching: geovax labs
GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update	Freshnews.com:  Nov 6 2009 3:07PM Matching: geovax labs
GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results	PR Newswire via MSN Money:  Nov 6 2009 2:25PM Matching: geovax labs
GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update	Red Orbit:  Nov 6 2009 5:14PM Matching: geovax labs
Promote your company here: BioNewsCast - Press Release Distribution	→View more Geovax Labs news.

Geovax Labs (GOVX.OB) Financial information Links from Barchart
GOVX.OB Quote from from Barchart.com
GOVX.OB Chart from from Barchart.com
GOVX.OB Profile from from Barchart.com
GOVX.OB Opinion from from Barchart.com
→View more Geovax Labs finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 867 times since April 2007, the link to the organisation's website has been followed 180 times

Recent Search Terms used to find this page: Geovax labs opinions | GeoVax DNA MVA 2009 | geovax opinion | geovax opinion | Geovax Labs | Geovax Labs | geovax labs govx | .

Search for more companies in Atlanta

Search for more companies in GA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Geovax Labs